Jeffrey Sean Healey

Q: What Schools Are Affiliated With Jeffrey Sean Healey

Jeffrey Sean Healey is affiliated with the following schools: University of Western Ontario, McGill University, Uppsala University, University of Alberta, University of British Columbia, McMaster University, Dalhousie University, Queen's University at Kingston, University of Toronto

Jeffrey Sean Healey's AcademicInfluence.com Rankings

Jeffrey Sean Healey

Philosophy

#7787

World Rank

#11042

Historical Rank

Logic

#4824

World Rank

#6153

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Jeffrey Sean Healey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey Sean Healey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardiac-resynchronization therapy for mild-to-moderate heart failure. (2010) (1559)
Subclinical atrial fibrillation and the risk of stroke. (2012) (1391)
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial (2011) (1141)
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range (2008) (892)
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. (2005) (833)
Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events (2014) (523)
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. (2012) (522)
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. (2016) (518)
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. (2014) (516)
Pacemaker or defibrillator surgery without interruption of anticoagulation. (2013) (468)
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. (2007) (462)
Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. (2005) (443)
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial (2012) (436)
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. (2014) (417)
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration (2017) (417)
Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation (2018) (377)
Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation Registry (2014) (325)
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. (2015) (276)
Perioperative atrial fibrillation and the long-term risk of ischemic stroke. (2014) (267)
Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) (2009) (256)
A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. (2011) (246)
Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. (2010) (237)
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W) (2008) (235)
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data (2006) (233)
Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial (2017) (224)
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) (2015) (222)
Irbesartan in patients with atrial fibrillation. (2011) (215)
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. (2016) (212)
Device‐Related Infection Among Patients With Pacemakers and Implantable Defibrillators: Incidence, Risk Factors, and Consequences (2010) (201)
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure (2014) (199)
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2016) (193)
Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study (2016) (190)
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. (2020) (188)
The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. (2016) (182)
Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. (2003) (179)
Subclinical Atrial Fibrillation in Older Patients (2017) (179)
Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands (2010) (171)
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. (2018) (171)
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. (2007) (170)
Complications associated with defibrillation threshold testing: the Canadian experience. (2008) (168)
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. (2021) (162)
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Elect (2017) (158)
Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. (2014) (149)
Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database (2011) (149)
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. (2011) (148)
Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT) (2012) (146)
Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2017) (144)
Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial (2015) (143)
Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry. (2011) (142)
Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study. (2016) (137)
Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle‐Aged Adults (2014) (137)
A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation (2009) (136)
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. (2019) (134)
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. (2013) (133)
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database (2012) (131)
Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. (2012) (128)
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial. (2019) (123)
Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials (2011) (123)
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2016) (121)
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society (2020) (121)
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis (2018) (115)
Clinical Predictors of Fidelis Lead Failure: Report From the Canadian Heart Rhythm Society Device Committee (2012) (113)
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) (2018) (106)
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. (2013) (104)
Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. (2003) (103)
Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators (2009) (100)
Cardioembolic Stroke. (2017) (100)
An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis (2018) (98)
Are Elderly Patients at Increased Risk of Complications Following Pacemaker Implantation? A Meta‐Analysis of Randomized Trials (2012) (97)
Complications Associated With Revision of Sprint Fidelis Leads: Report From the Canadian Heart Rhythm Society Device Advisory Committee (2010) (92)
Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly (2013) (92)
Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study. (2007) (91)
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). (2012) (90)
Management of atrial high-rate episodes detected by cardiac implanted electronic devices (2017) (89)
Human Study of Biatrial Electrical Coupling: Determinants of Endocardial Septal Activation and Conduction Over Interatrial Connections (2004) (89)
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals (2019) (88)
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. (2015) (88)
Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. (2013) (85)
Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. (2008) (84)
Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. (2008) (83)
Identifying Patients With Atrial Fibrillation in Administrative Data. (2016) (82)
Peri-Procedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin: Results from the RE-LY Randomized Trial (2012) (80)
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. (2012) (75)
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure. (2018) (73)
Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling (2005) (72)
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations. (2011) (71)
Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. (2013) (71)
Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. (2012) (69)
Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin (2009) (68)
Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial. (2021) (67)
Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. (2012) (66)
Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) (2017) (62)
Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (2016) (59)
A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation. (2015) (59)
Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection. (2013) (57)
Evaluation of Genes Encoding for the Transient Outward Current (Ito) Identifies the KCND2 Gene as a Cause of J-Wave Syndrome Associated With Sudden Cardiac Death (2014) (56)
Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation (2012) (55)
Ethnic Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices (2013) (53)
Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy. (2015) (52)
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studie (2012) (51)
Predictors of early and late stroke following cardiac surgery (2014) (51)
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. (2007) (50)
Prevalence and Risk Factors for Cervical and Lumbar Spondylosis in Interventional Electrophysiologists (2011) (50)
Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation (2012) (49)
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators (2015) (49)
Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT. (2012) (49)
Questioning patient engagement: research scientists’ perceptions of the challenges of patient engagement in a cardiovascular research network (2017) (49)
Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee. (2013) (49)
Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: no association with pacing mode or right ventricular pacing site. (2012) (47)
High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme (2016) (45)
Epinephrine Infusion in the Evaluation of Unexplained Cardiac Arrest and Familial Sudden Death: From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (2012) (45)
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]). (2017) (45)
Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). (2014) (45)
Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing (2010) (44)
Do Omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials (2011) (43)
Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure (2015) (42)
Population-Based Screening for Atrial Fibrillation. (2020) (42)
Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials (2018) (41)
The burden of atrial fibrillation on the hospital sector in Canada. (2013) (40)
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society (2015) (39)
The Prognostic Significance of Bundle Branch Block in High‐Risk Chronic Stable Vascular Disease Patients: A Report from the HOPE Trial (2009) (39)
Prognostic use of cardiac troponin T and troponin I in patients with heart failure. (2003) (39)
A Randomized‐Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial (2012) (39)
Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry. (2021) (39)
Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada. (2008) (39)
Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (2016) (39)
Atrial fibrillation is associated with increased mortality: causation or association? (2013) (38)
Predictors of Atrio‐Ventricular Conduction Disease, Long‐Term Outcomes in Patients with Myotonic Dystrophy Types I and II (2012) (38)
Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario. (2008) (38)
The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial. (2018) (38)
Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies (2018) (36)
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome. (2017) (35)
Improvement of apparently fixed pulmonary hypertension with cardiac resynchronization therapy. (2004) (35)
Sentinel Symptoms in Patients with Unexplained Cardiac Arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER) (2010) (34)
The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation. (2011) (34)
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing☆☆☆ (2016) (34)
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial. (2016) (34)
Relevance of Electrical Remodeling in Human Atrial Fibrillation: Results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial Mechanisms of Atrial Fibrillation Study (2012) (33)
Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design (2009) (33)
Atrial fibrillation detected initially during acute medical illness: A systematic review (2018) (32)
Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta‐analysis (2016) (32)
The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation. (2012) (31)
Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome. (2019) (31)
Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis. (2013) (30)
Impact of Cardiac Implantable Electronic Device Infection (2020) (30)
Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery (2020) (30)
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. (2019) (30)
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update (2021) (30)
Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey. (2014) (30)
Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration. (2020) (29)
Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. (2021) (29)
The management of patients with carotid sinus syndrome: is pacing the answer? (2004) (29)
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. (2020) (29)
Screening for Atrial Fibrillation Using a Mobile, Single-Lead Electrocardiogram in Canadian Primary Care Clinics. (2019) (29)
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial. (2017) (28)
Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines. (2017) (28)
Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads. (2014) (28)
Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy: The RAFT Upgrade Substudy (2015) (27)
Loss-of-Function KCNE2 Variants: True Monogenic Culprits of Long-QT Syndrome or Proarrhythmic Variants Requiring Secondary Provocation? (2017) (27)
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter AblationClinical Perspective (2017) (27)
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial (2017) (27)
Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group (2020) (26)
Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia. (2014) (26)
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial. (2016) (26)
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review (2017) (26)
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. (2012) (26)
EFFECT OF AGE AND RENAL FUNCTION ON THE RISKS OF STROKE AND MAJOR BLEEDING WITH DABIGATRAN COMPARED TO WARFARIN: AN ANALYSIS FROM THE RE-LY STUDY (2010) (25)
Atrial overdrive pacing in sleep apnoea: a meta-analysis. (2009) (25)
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia (2020) (25)
Society position statement (2012) (24)
Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee. (2009) (24)
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial (2022) (24)
Management of anticoagulation around pacemaker and defibrillator surgery. (2014) (23)
Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source (2020) (23)
The spectrum of intramyocardial small vessel disease associated with sudden death. (2002) (23)
Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial (2016) (23)
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153,152 middle-aged individuals. (2020) (22)
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation. (2021) (22)
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. (2005) (22)
Stroke Prevention in Atrial Fibrillation: Looking Forward. (2018) (22)
Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study. (2018) (22)
Clinical trials, the renin angiotensin system and atrial fibrillation (2006) (21)
Prevalence of risk factors for atrial fibrillation and stroke among 1210 patients with sleep disordered breathing. (2014) (21)
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation. (2019) (21)
Left atrial appendage occlusion debate revisited. (2015) (21)
Mexiletine or catheter ablation after amiodarone failure in the VANISH trial (2018) (21)
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older? (2018) (20)
Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation (2014) (20)
Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience. (2019) (19)
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration (2022) (19)
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. (2021) (19)
North American Thrombosis Forum, AF Action Initiative Consensus Document. (2016) (19)
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design. (2019) (19)
Atrial fibrillation occurring transiently with stress (2018) (19)
Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation. (2017) (19)
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial (2013) (18)
Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses. (2012) (18)
VDD vs DDD pacemakers: a meta-analysis. (2014) (18)
Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions. (2003) (18)
Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2. (2019) (18)
Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: a pilot randomized controlled study (2018) (18)
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population : The GENETIC-AF Trial (2019) (18)
Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation (2013) (18)
Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH (2018) (18)
Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). (2014) (18)
Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis (2018) (18)
Are We Ready for Mass Screening to Detect Atrial Fibrillation? (2015) (18)
Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2021) (17)
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial (2017) (17)
Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects. (2019) (17)
Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation (2015) (17)
Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis. (2019) (16)
Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program (2018) (16)
Life and death after ICD implantation. (2008) (16)
Right ventricular apical pacing: a necessary evil? (2007) (16)
Periprocedural management of oral anticoagulation in patients with atrial fibrillation: approach in the era of new oral anticoagulants. (2013) (16)
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. (2007) (16)
Phospholamban cardiomyopathy: a Canadian perspective on a unique population (2019) (15)
Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. (2016) (15)
Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Should Not Be Routinely Performed at the Time of Implantable Cardioverter Defibrillator Implantation (2014) (15)
Early Life Risk Factors for Incident Atrial Fibrillation in the Helsinki Birth Cohort Study (2017) (14)
Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under Advisory (2016) (14)
Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis. (2019) (14)
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. (2018) (14)
Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis (2012) (14)
Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery. (2015) (14)
Tricuspid Valve Regurgitation Following Temporary or Permanent Endocardial Lead Insertion, and the Impact of Cardiac Resynchronization Therapy (2014) (14)
Echocardiographic diagnosis of right ventricular thromboembolism. (1983) (13)
Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial (2016) (13)
The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee. (2013) (13)
Insight into the mechanism of failure of the Riata lead under advisory. (2015) (13)
Evaluating the feasibility of conducting a trial using a patient decision aid in implantable cardioverter defibrillator candidates: a randomized controlled feasibility trial (2017) (13)
Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction (2020) (13)
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. (2019) (13)
Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design (2015) (12)
The evolving role of stroke prediction schemes for patients with atrial fibrillation. (2013) (12)
Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators. (2020) (12)
Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) follow‐up cohort study (2018) (12)
Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? (2019) (12)
Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials. (2019) (11)
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C‐CUSP ED) (2019) (11)
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. (2013) (11)
Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG. (2004) (11)
Approaches to empiric ablation of slow pathway: results from the Canadian EP web survey (2012) (11)
The Relationship Between Atrial High-Rate Episodes and Stroke: The Asymptomatic Stroke and Atrial Fibrillation Evaluation in Pacemaker Patients (ASSERT) Trial (2010) (11)
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial. (2014) (11)
The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring. (2015) (10)
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) (2019) (10)
Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group. (2019) (10)
Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial. (2019) (10)
A genotype‐directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC‐AF trial (2017) (10)
Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy. (2016) (10)
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator (2022) (10)
Registry on the evaluation of syncope assessment strategy in the emergency room (RESASTER study) (2005) (9)
Apical versus Non‐Apical Lead: Is ICD Lead Position Important for Successful Defibrillation? (2016) (9)
Management of dyspepsia symptoms on dabigatran during RELY-ABLE : long-term follow up study after RE-LY (2013) (9)
Troponin elevation in patients with supraventricular tachycardia: what does it mean? (2011) (9)
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada. (2006) (9)
The new Canadian Cardiovascular Society algorithm for antithrombotic therapy of atrial fibrillation is appropriately based on current epidemiologic data. (2015) (9)
Screening for undiagnosed atrial fibrillation (2018) (9)
The effect of atrial-based pacing on exercise capacity as measured by the 6-minute walk test: a substudy of the Canadian Trial of Physiological Pacing (CTOPP). (2007) (9)
Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis (2018) (9)
Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy. (2017) (9)
The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations. (2018) (9)
How to Manage a High Defibrillation Threshold in ICD Patients: and Does it Really Matter? (2013) (9)
Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation (2020) (8)
New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010 (2009) (8)
Remote Ambulatory Cardiac Monitoring Before and After Transcatheter Aortic Valve Replacement (2020) (8)
Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden (2018) (8)
Early Repolarization Pattern Inheritance in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). (2018) (8)
The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network (2020) (8)
Safety of urgent cardioversion for patients with recent-onset atrial fibrillation and flutter. (2015) (8)
Stroke prevention in patients with atrial fibrillation: the diagnosis and management of hypertension by specialists. (2006) (8)
Perspective and practice of surgical atrial fibrillation ablation: an international survey of cardiac surgeons (2018) (8)
Device-Detected Atrial Fibrillation Before and After Hospitalization for Non-cardiac Surgery or Medical Illness: Insights from ASSERT. (2020) (7)
Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee. (2009) (7)
Cardiac implantable electronic device infections: From recognizing risk to prevention. (2017) (7)
Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients (2018) (7)
The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape. (2021) (7)
Prevalence of undiagnosed atrial fibrillation in elderly individuals and potential cost-effectiveness of non-invasive ambulatory electrocardiographic screening: The ASSERT-III study. (2019) (7)
Abstract 9174: Global Variation in the Etiology and Management of Atrial Fibrillation: Results from a Global Atrial Fibrillation Registry (2011) (7)
Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation” (2009) (7)
Pacemakers, recent directions and developments (2002) (7)
Searching for Atrial Fibrillation Poststroke (2019) (7)
Stroke prevention in atrial fibrillation: Closing the gap (2019) (7)
ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II) (2015) (6)
Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis (2021) (6)
Delayed AICD therapy and cardiac arrest resulting from undersensing of ventricular fibrillation in a subject with hypertrophic cardiomyopathy–A case report (2015) (6)
Effectiveness of single‐ vs dual‐coil implantable defibrillator leads: An observational analysis from the SIMPLE study (2019) (6)
Outcomes and Safety of Fluoroless Catheter Ablation for Atrial Fibrillation (2020) (6)
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Catheter Ablation or Antiarrhythmic Drug Therapy: A Systematic Review and Meta-analysis (2020) (6)
Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes (2020) (6)
New‐Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Risk of Adverse Events: An Analysis From the CORONARY Trial (2021) (6)
The Canadian Arrhythmogenic Right Ventricular Cardiomyopathy Registry: Rationale, Design, and Preliminary Recruitment. (2016) (6)
Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol (2017) (6)
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial. (2019) (5)
Response to Letter Regarding Article, "Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry". (2016) (5)
The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients (2017) (5)
Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registry (2014) (5)
Unconventional warfare: Successful ablation of ventricular tachycardia by direct ventricular puncture in a patient with double mechanical heart valves (2017) (5)
Gastroesophageal reflux and atrial fibrillation: is there any correlation? (2012) (5)
Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation. (2018) (5)
Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trials. (2020) (5)
Bidirectional ventricular tachycardia secondary to subacute myocarditis. (2013) (5)
Nonphysiologic noise early after defibrillator implantation in Canada: incidence and implications: a report from the Canadian Heart Rhythm Society Device Committee. (2012) (5)
A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation. (2019) (5)
Catheter Ablation of Hemodynamically Unstable Ventricular Tachycardia in a Patient with Dextro - Transposition of the Great Arteries and Mustard's Repair (2011) (5)
Modifiable risk factors predict incident atrial fibrillation and heart failure (2020) (5)
GENETIC-AF: Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined Heart Failure Population. (2019) (5)
Greater mortality risk among patients with delayed follow-up after implantable cardioverter defibrillator procedures. (2013) (5)
The RACE to Treat Atrial Fibrillation in the Emergency Department. (2019) (5)
PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II) (2015) (5)
Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis (2021) (5)
Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study (2021) (4)
Canadian Registry of Implantable Electronic Device Outcomes: Longer-term follow-up of the Riata lead under advisory. (2017) (4)
Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker (2015) (4)
Epsilon waves during ventricular tachycardia in a case of arrhythmogenic right ventricular dysplasia. (2010) (4)
Subclinical atrial fibrillation: The significance of progression to longer episodes. (2017) (4)
Are there increased periprocedural complications with the MRI-conditional Medtronic Revo SureScan Pacing System? (2018) (4)
The left atrium: An overlooked prognostic tool (2017) (4)
on behalf of the RE-LY Atrial Fibrillation Registry Investigators (2014) (4)
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
Importance of genetic testing in unexplained cardiac arrest (2022) (4)
Detection of atrial fibrillation in asymptomatic at-risk individuals. (2021) (4)
Device surgery without interruption of anticoagulation. (2013) (4)
Device-detected atrial tachyarrhythmias: what do we know? (2012) (4)
Association Between Perioperative Atrial Fibrillation and Long-term Risks of Stroke and Death in Noncardiac Surgery: Systematic Review and Meta-analysis (2021) (4)
Response to letter regarding article "Temporal relationship between subclinical atrial fibrillation and embolic events". (2015) (4)
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease. (2021) (4)
Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES (2020) (4)
Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal? (2018) (4)
Incidence and Predictors of Heart Failure in Patients With Atrial Fibrillation (2021) (4)
Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice (2018) (3)
Trifecta or triple threat? The challenge of post-PCI management in patients receiving chronic oral anticoagulant therapy. (2013) (3)
LVS‐HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World‐Wide Registry (2021) (3)
Pseudoaneurysm of the left ventricle diagnosed by two dimensional echocardiography. (1982) (3)
A rare cause of implantable cardioverter-defibrillator failure: short-circuiting via an unused pace/sense lead. (2010) (3)
Bad lead? Good lead? What should we believe? (2009) (3)
While My Guitar Gently Weeps (2011) (3)
Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) incidence study. (2019) (3)
Abstract 4661: Impact of Alerts on Outcome of the Fidelis Implantable Cardioverter-Defibrillator Lead Advisory: A Report from the Canadian Heart Rhythm Society Device Advisories Committee (2008) (3)
ATRIAL FIBRILLATION OCCURRING TRANSIENTLY WITH STRESS DURING MEDICAL ILLNESS: A SYSTEMATIC REVIEW (2016) (3)
Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation? (2016) (3)
Oral anticoagulant use in patients with chronic kidney disease: how to choose, and the importance of empiric human data. (2014) (3)
Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories (2021) (3)
Double twiddle trouble, a new variant of twiddler syndrome (2016) (3)
Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation (2018) (3)
Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: A systematic review (2020) (3)
Society Guidelines 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation (2014) (3)
Does catheter ablation for atrial fibrillation increase or reduce neurological insult? (2012) (3)
Contralateral Pneumothorax in Left Sided CRT Device Implantation (2011) (3)
Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. (2021) (3)
Automatic implantable cardioverter defibrillator lead dislodgement resulting in sudden cardiac death: a case report. (2014) (3)
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype (2021) (2)
Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring". (2016) (2)
Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis. (2016) (2)
Antiplatelet Therapy in Patients with Atrial Fibrillation: A Systematic Review and Metaanalysis of Randomized Trials. (2021) (2)
Response to letter regarding article, "Survival after implantable cardioverter-defibrillator implantation in the elderly". (2014) (2)
The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation (2018) (2)
Pre-Screening for Atrial Fibrillation Using the Electronic Health Record. (2019) (2)
Abstract 117: Application Of A Delphi Method To Develop A Patient Decision Aid For Implantable Cardioverter Defibrillator Candidates (2013) (2)
Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial (2020) (2)
ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts (2018) (2)
Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial. (2019) (2)
Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion. (2013) (2)
Who is at risk of atrial fibrillation? (2021) (2)
Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing (2018) (2)
ARRHYTHMIC OUTCOMES IN CARDIAC ARREST SURVIVORS WITH PRESERVED EJECTION FRACTION REGISTRY (CASPER) (2018) (2)
Bilateral Pneumothorax Post Insertion of Intracardiac Defibrillator, a Rare Condition, Risk Factors and Prevention (2016) (2)
Descriptive analysis of pharmacy services provided after community pharmacy screening (2018) (2)
Abstract 12041: The Risk of Peri-Operative Bleeding with Warfarin Compared to Two Doses of Dabigatran: Results From the RE-LY Trial (2011) (2)
New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. (2022) (2)
Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey (2019) (2)
[Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study]. (2013) (2)
Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads. (2018) (2)
Physiologic pacing: where pacing mode selection reflects the indication (2004) (2)
Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial (2021) (2)
Prospective long-term follow-up of silicone-polyurethane–insulated implantable cardioverter-defibrillator leads (2021) (2)
Aspirin and the Risk of Heart Failure Hospitalization in Patients with Atrial Fibrillation and a Prior History of Heart Failure: An ACTIVE-W Analysis (2006) (2)
Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada (2020) (2)
Atrial fibrillation and stroke: chicken or egg? Does it really matter? (2020) (2)
Metagenomic Analysis of Tuberculosis — Current Limitations (2013) (2)
Abstract 14972: Sub-clinical Atrial Fibrillation in Elderly Primary Care Patients Without Clinical Atrial Fibrillation (2015) (2)
EXAMINING PERCEPTIONS OF BARRIERS TO PATIENT ENGAGEMENT IN CLINICAL RESEARCH AMONG RESEARCH SCIENTISTS IN A CARDIOVASCULAR RESEARCH NETWORK (2016) (2)
Does left atrial appendage occlusion eliminate the need for warfarin (2009) (2)
REDUCTION IN UNNECESSARY VENTRICULAR PACING FAILS TO AFFECT HARD CLINICAL OUTCOMES: A META-ANALYSIS (2015) (2)
“I don’t know exactly what you’re referring to”: the challenge of values elicitation in decision making for implantable cardioverter-defibrillators (2018) (1)
PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY (2017) (1)
STROKE RISK PREDICTION IN PATIENTS WITH ATRIAL FIBRILLATION AND RHEUMATIC HEART DISEASE: RESULTS FROM THE RE-LY AF REGISTRY (2019) (1)
Study Protocol Summary (2012) (1)
Is Screening for Atrial Fibrillation and Its Risk Factors Useful and Cost-Effective? (2021) (1)
Canadian Heart Rhythm Society Task Force Report on Physician Training and Maintenance of Competency For Cardiovascular Implantable Electronic Device Therapies: Educating Future Generations Of Canadian Physicians. (2021) (1)
VARIANT RE-INTERPRETATION IN SURVIVORS OF CARDIAC ARREST WITH PRESERVED EJECTION FRACTION (CASPER REGISTRY) BY CLINICIANS AND CLINICAL COMMERCIAL LABORATORIES (2020) (1)
Advances in Cardiac Electrophysiology. (2022) (1)
Risk of Bias Assessment Tool (2012) (1)
Erratum to ‘2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-deﬁbrillator programming and testing’ [Journal of Arrhythmia 32/1 (2016) 1–28] (2016) (1)
Harder Roads to Trek? Paradoxical Slowing of an Atrioventricular Reentrant Tachycardia With Contralateral Bundle Branch Block (2017) (1)
Current Attitudes towards Oral Anticoagulant Use to Treat Cardiac Device Patients with Subclinical Atrial Fibrillation : Results from a Four-Nation Physician Survey (2015) (1)
A Case of Long‐RP Tachycardia: What is the Mechanism? (2009) (1)
HOW WELL ARE RATE OR RHYTHM CONTROL ACHIEVED IN RAFT-AF PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE? (2015) (1)
What Do Implanted Cardiac Monitors Reveal About Atrial Fibrillation? (2017) (1)
Incident Atrial Fibrillation and Stroke in Patients With Atrial Flutter. (2018) (1)
Abstract 20441: Combined Assessment of Autonomic Tone and Cardiac Repolarization Identifies Patients With Better-Preserved Left Ventricular Systolic Function at High Risk of Death Following a Myocardial Infarction (2016) (1)
Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients (2011) (1)
Abstract 18936: Can Biomarkers Improve Risk Stratification of Atrial Fibrillation Patients? Analysis of 3578 Aspirin-treated Patients in ACTIVE and AVERROES (2014) (1)
Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations. (2019) (1)
Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
Reviewers for the Journal, January-June 2016. (2016) (1)
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy. (2018) (1)
ETIOLOGY OF CARDIAC ARREST IN THE ABSENCE OF MANIFEST STRUCTURAL HEART DISEASE - UPDATE FROM THE CASPER PROSPECTIVE COHORT (2014) (1)
Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status. (2021) (1)
ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (2004) (1)
Remote ECG monitoring to reduce complications following transcatheter aortic valve implantations: the Redirect TAVI study. (2021) (1)
ENGAGING PATIENTS AND FAMILIES DURING DEVELOPMENT OF A PATIENT DECISION AID (PTDA) FOR AN IMPLANTABLE DEFIBRILLATOR - ACCEPTABILITY RESULTS (2014) (1)
Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS2 Score: Insights From the BRAIN-AF Trial. (2022) (1)
Abstract 10994: Heart Failure in Patients with Sick Sinus Syndrome Treated with Single And Dual Chamber Pacing - No Association with Pacing Mode or Right Ventricular Pacing Site (2011) (1)
Implantable Cardioverter-Defibrillator and Lipomas: A Case-Series (2021) (1)
SURGICAL ABLATION OF ATRIAL FIBRILLATION IN 11 COUNTRIES: THE LAAOS III TRIAL (2016) (1)
Response by Parkash et al to Letters Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])". (2017) (1)
Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. (2021) (1)
O095 Referral Bias among Electrophysiologists performing atrial fibrillation radio-frequency ablation (AF-RFA) vs electrophysiologists not performing AF-RFA: A randomized evaluation (2014) (1)
QUALITY OF LIFE IN PATIENTS WITH ABLATION OR MEDICAL THERAPY FOR VENTRICULAR ARRHYTHMIAS: A SUBSTUDY OF VANISH (2017) (1)
4. Syncope Evaluation & Syncope Unit4.2 Registry on the Evaluation of Syncope Assessment Strategy in the Emergency Room (Resaster Study) (2005) (1)
Pacemakers and Implantable Cardioverter Defibrillators in the Elderly (2011) (1)
At What Age Does Stroke Risk Increase in Patients With Atrial Fibrillation? Does It Depend on Where You Live? (2016) (1)
Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis (2021) (1)
Alcohol Consumption and Atrial Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-analysis. (2022) (1)
Benefits of left atrial appendage occlusion (2006) (1)
RHYTHM VERSUS RATE CONTROL IN PATIENTS WITH POSTOPERATIVE ATRIAL FIBRILLATION FOLLOWING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (1)
EMBOLIC STROKE OF UNDETERMINED SOURCE: CURRENT PERSPECTIVES ON DIAGNOSIS, INVESTIGATIONS AND MANAGEMENT. (2022) (1)
THE IMPACT OF EMPIRICAL LEFT ATRIAL APPENDAGE ISOLATION IN ATRIAL FIBRILLATION CATHETER ABLATION: A META-ANALYSIS (2017) (1)
SCREENING FOR ATRIAL FIBRILLATION VIA MOBILE ECG IN CANADIAN PRIMARY CARE PRACTICE: A FEASIBILITY EVALUATION (2018) (1)
Assessment of Radiation-Induced Malfunction in Cardiac Implantable Electronic Devices (2021) (1)
Late Stroke After Coronary Artery Bypass Grafting. (2018) (1)
The role of defibrillation testing. (2015) (1)
The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial (2021) (1)
Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study (2020) (1)
Active-fixation Atrial Leads and the Risk of Atrial Fibrillation: Insights from ASSERT. (2020) (1)
Abstract 4665: CASPER: Study Design and Preliminary Results in Probands from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (2008) (1)
Abstract 11042: New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis (2021) (0)
THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA (2014) (0)
LONG-TERM RISK OF STROKE AFTER AN EPISODE OF ATRIAL FIBRILLATION OCCURRING TRANSIENTLY WITH STRESS FOLLOWING NON-CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2018) (0)
Echocardiographic Assessment of Tricuspid Valve Regurgitation Induced by Temporary or Permanent Leads in Patients Undergoing Ablation or Permanent Device Implantation (2013) (0)
Gastroesophageal reflux and atrial fibrillation: is there any (2012) (0)
Figure 16, Rankogram for Unadjusted Fixed-Effects Bayesian MTC Results for Major Bleeding Compared with Adjusted-Dose Warfarin (2012) (0)
Special Issue and Abstracts of the 10th Annual Congress of the European Cardiac Arrhythmia Society (2014) (0)
Abstract 15178: Population-Based Evaluation of Appropriate Therapies and Death Among Elderly Implantable Cardioverter Defibrillator (ICD) Recipients: The Ontario ICD Database (2012) (0)
Figure 21, Rankogram for Unadjusted Fixed-Effects Bayesian MTC Results for Intracranial Bleeding (2012) (0)
COMPARISON OF HEALTH RELATED QUALITY OF LIFE IN ATRIAL FIBRILLATION PATIENTS TREATED WITH CATHETER ABLATION OR ANTIARRHYTHMIC DRUG THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2017) (0)
Reply to the Editor--Shocks and mortality versus pacing and mortality. (2013) (0)
THE RESPONSE TO ANTITACHYCARDIA PACING DIFFERENTIATES VENTRICULAR FROM SUPRAVENTRICULAR TACHYCARDIA (2014) (0)
A Mutation Hotspot in KCNH2 associated with Short QT Syndrome, SCD and SIDS (2011) (0)
Non-pharmacological interventions to improve the success of electrical cardioversion in patients with atrial fibrillation (2021) (0)
THE SIMPLE TRIAL: A LARGE ICD IMPLANT COHORT SHOWING A LOW RATE OF INFECTION (2016) (0)
Abstract 11232: Utility of Adrenaline Infusion in Evaluation of Patients with Familial Sudden Death and Unexplained Cardiac Arrest (2011) (0)
SURGICAL ABLATION OF ATRIAL FIBRILLATION EVALUATION (SAFE): A COST ANALYSIS (2017) (0)
Abstracts: Ventricular Fibrillation Induction at implant: hot issues (2009) (0)
4. Syncope Evaluation & Syncope Unit4.3 The Role of the Emergency Medical System in the Assessment and Management of Syncope (2005) (0)
Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis (2022) (0)
Table 24, Summary of Results from the MTC Network Meta-analyses — Odds Ratio (95%CrI) for Each Outcome* (2012) (0)
Random-Effects Frequentist GLMM Network Meta-analysis (2012) (0)
PREDICTORS OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SHOCK AND DEATH: A COMPETING RISK ANALYSIS (2014) (0)
NT-PROBNP PREDICTS RECURRENCE AFTER CATHETER ABLATION IN A HYPERTENSIVE POPULATION UNDERGOING AGGRESSIVE BLOOD PRESSURE MANAGEMENT: A SUB-STUDY OF SMAC-AF (2019) (0)
Renal Sympathetic Denervation: Using an Old Tool for a New Job? (2013) (0)
Table 58, Summary of Study-Level Results for All-Cause Mortality Compared with Adjusted-Dose Warfarin (2012) (0)
PREDICTORS OF ATRIAL FIBRILLATION AFTER CATHETER ABLATION IN A HYPERTENSIVE POPULATION: A SUB-STUDY OF SMAC-AF (2017) (0)
445 Discovering heart disease in first degree relatives of sudden death victims: A preliminary report from the casper registry (2011) (0)
Abstract 3700: Impact of Vascular Events on Mortality in AF Patients: Insights from ACTIVE W (2006) (0)
Systematic review of treatment gaps in oral anticoagulant use in atrial fibrillation (2021) (0)
Figure 15, Rankograms for Fixed-Effects Bayesian MTC for All-Cause Stroke/Systemic Embolism Compared with Adjusted-Dose Warfarin for CHADS2 ≥ 2 (2012) (0)
Complications of defibrillation testing (2015) (0)
Figure 5, Rankograms for Bayesian MTC Network Meta-analysis — for Each Outcome* (2012) (0)
Figure 23, Rankogram for Unadjusted Fixed-Effects Bayesian MTC Results for Major Gastrointestinal Bleeding (2012) (0)
Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation an analysis from the SIMPLE study (2018) (0)
FEASIBILITY AND EFFECT OF REMOTE AMBULATORY HEART RHYTHM MONITORING PRE AND POST TAVI (2019) (0)
Abstract 13047: Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators (ICDs) (2014) (0)
Abstract 9791: Sex Disparities in Implantable Cardioverter Defibrillator (ICD) Outcomes: Findings From the Ontario ICD Database (2011) (0)
Bleeding and thromboembolic outcomes in warfarin-and dabigatran-treated patients in the RE-LY trial who required an urgent surgery or procedure (2015) (0)
Anticoagulation for atrial fibrillation: state of the art and recommendations for a quickly moving target. (2013) (0)
Previous history of hyperthyroidism in emergency department patients with atrial fibrillation does not increase the risk of thromboembolism and death. (2022) (0)
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations (2022) (0)
Table 46, Subgroup Data Reporting — Comparison By Trial (2012) (0)
Clinical Outcomes in Atrial Fibrillation Research: Shining a Light on a New Path. (2019) (0)
Predictors of Pacemaker Dependency and Heart Failure Hospitalizations in Pacemaker Patients in the Assert Trial (2013) (0)
B-011-22 MACHINE LEARNING TO PREDICT RECURRENT EVENTS FOLLOWING UNEXPLAINED CARDIAC ARREST (2021) (0)
PRE- AND POST-TREATMENT WITH ANTIARRHYTHMIC DRUGS FOR ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A NETWORK META-ANALYSIS (2019) (0)
Device-detected atrial fibrillation before and after acute cardiac events: insights from ASSERT (2021) (0)
Abstract 128: Evolution of Clinical Diagnosis in Patients Presenting with Unexplained Cardiac Arrest (2011) (0)
Table 53, Summary of Study-Level Results for Major Bleeding Compared with Adjusted-Dose Warfarin (2012) (0)
Consistent Inconsistency? Is There Pacemaker Malfunction? (2016) (0)
Management of dyspepsia symptoms on dabigatran during RELY-ABLE : a long-term follow up of RE-LY patients. (2014) (0)
Erratum to: Society position statement (2012) (0)
PRE- AND POST-TREATMENT WITH AMIODARONE FOR ELECTIVE ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2019) (0)
PILOT STUDY TO ASSESS THE FEASIBILITY OF REMOTE ONLY FOLLOW-UP FOR CARDIAC IMPLANTABLE ELECTRONIC DEVICES (2019) (0)
A single-center experience in transvenous coronary sinus lead extraction and re-implantation. Technical issues and alternative re-implantation approaches (2013) (0)
Table 52, Results from Fixed-Effects Bayesian MTC Sub-Group Analysis for All-Cause Stroke/Systemic Embolism Compared with Adjusted-Dose Warfarin By CHADS2 (2012) (0)
Perioperative Management of Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Surgery: A Survey of Canadian Centers (2013) (0)
500 Left ventricular lead position in raft - evaluating the agreement between implant and blinded post-operative chest radiograph categorization (2011) (0)
SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS AND ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2021) (0)
Response to Letter Regarding Article, “Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT)” (2013) (0)
Abstract 14750: Incidence of Cardiac Implantable Electronic Device Malfunction Post Radiation Therapy (2017) (0)
Response to Letter Regarding Article, "Left Atrial Appendage Occlusion Debate Revisited". (2015) (0)
Agenda - Morning Session (2014) (0)
HEART FAILURE OUTCOMES AND PREDICTORS OF SUBCLINICAL ATRIAL FIBRILLATION PROGRESSION (2017) (0)
Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study (2014) (0)
Application of the American College of Emergency Physicians (ACEP) recommendations and a risk stratification score (OESIL) for patients with syncope admitted in internal medicine service (2005) (0)
Wednesday, 29 August 2012 (2012) (0)
Table 64, Summary of Study-Level Results for Major Gastrointestinal Bleeding Compared with Adjusted-Dose Warfarin (2012) (0)
Included and Excluded Studies (2012) (0)
Random Effects MTC Network Meta-analysis Results versus adjusted-dose warfarin (2012) (0)
Prediction, and COMPARISON OF THE EFFICACY OF BI-V VS RV BURST ATP IN TERMINATING VT IN PATIENTS WITH NON-ISCHEMIC VS ISCHEMIC CARDIOMYOPATHY (2022) (0)
Abstract 17060: Implantable Cardioverter Defibrillator Events and Mortality in Unexplained Cardiac Arrest Subjects in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) (2013) (0)
Recent Advances in Stroke Prevention among Elderly Patients with Atrial Fibrillation (2014) (0)
Sex Differences and Utility of Treadmill Testing in Long‐QT Syndrome (2022) (0)
Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen? (2019) (0)
PATIENT SELECTION, REGION AND TREATING PHYSICIAN ARE RELATED TO ESTIMATES OF ORAL ANTICOAGULATION USE IN ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2020) (0)
No Defibrillation Testing Best for ICD Implantation (2014) (0)
Abstract 10249: Association of Eligibility for a Sodium-Glucose Co-Transporter 2 Inhibitor and Cardiovascular Outcomes in Patients with Atrial Fibrillation (2021) (0)
Table 48, Summary of Study-level Results for All-Cause Stroke/Systemic Embolism Compared with Adjusted-Dose Warfarin (2012) (0)
Resetting of a Supraventricular Tachycardia by a Ventricular Premature Beat. What is the Mechanism? (2015) (0)
CARDIAC RESYNCHRONIZATION THERAPY REDUCES THE INCIDENCE OF VENTRICULAR ARRHYTHMIAS IN PRIMARY BUT NOT SECONDARY PROPHYLACTIC ICD PATIENTS: A SUBSTUDY OF THE RAFT TRIAL (2015) (0)
Table 63, Summary of Unadjusted Fixed-Effects Bayesian MTC Results for Myocardial Infarction Compared with Adjusted-Dose Warfarin (2012) (0)
Abstract 210: Association between Paroxysmal Supraventricular Tachycardia and Ischemic Stroke in Patients Without Atrial Fibrillation (2016) (0)
Abstract 2438: Complications Increase Mortality Risk After De Novo Implantion of a Cardioverter Defibrillator: Initial Findings From the Ontario ICD Database (2009) (0)
VASOPRESSIN VERSUS CATECHOLAMINERGIC VASOPRESSORS IN THE TREATMENT OF VASODILATORY SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE IMPACT ON ATRIAL FIBRILLATION, MYOCARDIAL INJURY AND MORTALITY (2017) (0)
Case Report Bidirectional Ventricular Tachycardia Secondary to Subacute Myocarditis (2013) (0)
PRE-TREATMENT WITH AMIODARONE FOR ELECTIVE ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2018) (0)
Table 60, Summary of Study-level Results for Intracranial Bleeding Compared with Adjusted-Dose Warfarin (2012) (0)
Figure 20, Rankogram for Unadjusted Fixed-Effects Bayesian MTC Results for All-Cause Mortality (2012) (0)
ISPOR 14th annual European congress research abstractPoster session II: Disease-specific studies: Cardiovascular disorders – cost studyPCV50 Hospital Costs Associated with Atrial Fibrillation in Canada (2011) (0)
Abstract 3498: Neither Ramipril Nor Vitamin E Reduces the Incidence of Atrial Fibrillation. Results of the HOPE Study. (2006) (0)
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality. (2023) (0)
Anti-diabetic drugs for preventing atrial fibrillation: a new revolution? (2021) (0)
SIGN50 Quality Assessment Instrument for RCT (2012) (0)
Figure 13, Rankograms for Fixed-Effects Bayesian MTC for All-Cause Stroke/Systemic Embolism Compared with Adjusted-Dose Warfarin By Time in Therapeutic Range (2012) (0)
Specific Outcome Results (2012) (0)
Temporal Association of Atrial Fibrillation with Device Based Heart Failure Status in Patients with CRT (2019) (0)
444 Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression (2021) (0)
EARLY REPOLARIZATION INHERITANCE PATTERN IN CARDIAC ARREST SURVIVORS WITH PRESERVED EJECTION FRACTION REGISTRY (CASPER) (2015) (0)
Chapter 10 – Clinical Trials of Pacing Modes (2007) (0)
Table 54, Summary of Unadjusted Fixed-Effects Bayesian MTC Results for Major Bleed Compared with Adjusted-Dose Warfarin (2012) (0)
Achieving Consensus About Content to Include in a Decision Aid for Implantable Defibrillator Candidates: Use of the Delphi Process (2013) (0)
Limitations of Administrative Data for Examining Secondary Atrial Fibrillation. (2018) (0)
Abstract 15687: Early Repolarization and Implantable Cardioverter Defibrillator Events in Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) (2015) (0)
Figure 19, Rankograms for Fixed-Effects Bayesian MTC for Major Bleeding Compared with Adjusted-Dose Warfarin for CHADS2 ≥ 2 (2012) (0)
OP-EHEA180582 1..13 (2018) (0)
Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis. (2022) (0)
PREVENTION OF VENOUS THROMBOSIS AFTER ELECTROPHYSIOLOGY PROCEDURES: A SURVEY OF CANADIAN PRACTICE (2018) (0)
THE UTILITY AND INCREMENTAL VALUE OF THE SIGNAL AVERAGED ECG: A NOVEL MODEL FOR STRATIFYING PATIENTS WITH SUSPECTED BRUGADA SYNDROME (2015) (0)
Antiplatelets in patients with atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials (2021) (0)
How Useful is Computed Tomography of the Chest for the Diagnosis of Asymptomatic Right Ventricular Perforation Following Pacemaker Insertion (2016) (0)
OC11_04 Antithrombotic Therapy in Relation to Symptoms in Patients With Atrial Fibrillation: Observations From The Gloria-AF Registry Program (2016) (0)
Entrainment of supraventricular tachycardia: what is the mechanism? (2011) (0)
SENSITIVITY AND SPECIFICITY OF CHEST IMAGING FOR SCREENING OF SARCOIDOSIS IN PATIENTS WITH CARDIAC PRESENTATIONS: INSIGHTS FROM THE CHASM-CS REGISTRY (2016) (0)
PRESCRIPTION OF ORAL ANTICOAGULATION IN PATIENTS WITH A PRIMARY OR SECONDARY DIAGNOSIS OF ATRIAL FIBRILLATION WHO ATTEND THE EMERGENCY DEPARTMENT (2019) (0)
Impact of Additional Left Atrial Lines on AF Recurrence in Patients Undergoing Pulmonary Vein Isolation Redo Procedure (2013) (0)
Flash Presentations II (2011) (0)
Dislodgement of an Active-Fixation Right Atrial Lead Causing Subacute Right Ventricular Perforation and Pericardial Effusion (2011) (0)
EFFICACY OF BURST VS RAMP ANTITACHYCARDIA PACING AFTER FAILED BURST ANTITACHYCARDIA PACING (2023) (0)
Return of Results Policies for Genomic Research: Current Practices & The Hearts in Rhythm Organization Approach. (2021) (0)
901 Does cardiac resynchronization therapy improve outcomes in patients with chronic atrial tachyarrhythmias? Results from the resynchronization for ambulatory heart failure trial (RAFT) (2011) (0)
Reply to the Editor—Electrogram Confirmation of Atrial High-Rate Episodes (2012) (0)
Systematic Assessment of Patients With Unexplained Syncope and Polymorphic Ventricular Tachycardia in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) (2013) (0)
How Much Atrial Fibrillation is Enough to Warrant Oral Anticoagulation: Management of Subclinical Atrial Fibrillation? (2018) (0)
A clinical dilemma: the longer the higher the risk?-Authors' reply. (2022) (0)
P2-118: Will implementing a syncope assessment algorithm at emergency room reduce hospital admissions and health care costs? (2006) (0)
Omega-3 fatty acids and sudden arrhythmic death. (2006) (0)
Association of Eligibility for a Sodium-Glucose Co-transporter 2 Inhibitor and Cardiovascular Events in Patients with Atrial Fibrillation. (2022) (0)
DELAYED AV CONDUCTION PREDICTS OUTCOME IN THE RESYNCHRONIZATION-DEFIBRILLATION FOR AMBULATORY HEART FAILURE TRIAL (RAFT) (2015) (0)
Clinical outcomes in patients with systolic heart failure. Are atrial high rate episodes a common marker of disease progression? (2020) (0)
SAFETY OUTCOMES WITH ANESTHESIOLOGIST DIRECTED SEDATION COMPARED TO NON-ANESTHESIOLOGIST FOR DEFIBRILLATION THRESHOLD TESTING (2017) (0)
ENGAGING PATIENT PARTNERS TO IDENTIFY ATRIAL FIBRILLATION RESEARCH PRIORITIES-RESULTS FROM A PATIENT ENGAGEMENT WORKSHOP (2018) (0)
CARDIAC ABNORMALITIES IN RELATIVES OF SUDDEN CARDIAC ARREST VICTIMS: A REPORT FROM THE CASPER REGISTRY (2015) (0)
Abstract 10238: Left Ventricular Lead Position and Long-Term Clinical Outcome in the RAFT Trial (2011) (0)
Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area (2013) (0)
RATIONALE AND DESIGN OF THE PROGRAM FOR THE IDENTIFICATION OF “ACTIONABLE” ATRIAL FIBRILLATION (PIAAF): SYSTEMATIC IDENTIFICATION TO DETECT PREVIOUSLY UNDIAGNOSED OR UNTREATED AF IN THE COMMUNITY (2014) (0)
Table 19, Summary of Individual Study Results — Odds Ratio (95% CI) for Each Outcome* (2012) (0)
Figure 12, Rankogram for Unadjusted Fixed-Effects Bayesian MTC Results for All-cause Stroke/Systemic Embolism Compared with Adjusted-Dose Warfarin (2012) (0)
In Memoriam: George Wyse (1941-2022). (2022) (0)
Table 49, Summary of Unadjusted Fixed-Effects Bayesian MTC Results for All-cause Stroke/Systemic Embolism Compared with Adjusted-Dose Warfarin (2012) (0)
SINGLE ORAL DOSE ANTI-ARRHYTHMIC DRUGS FOR CARDIOVERSION OF RECENT-ONSET ATRIAL FIBRILLATION EPISODES: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2020) (0)
Table 62, Summary of Study-Level Results for Myocardial Infarction Compared with Adjusted-Dose Warfarin (2012) (0)
100 years of magma evolution at Sakurajima volcano, Japan (2019) (0)
Differences in baseline electrophysiologic properties and electrical remodeling among pacemaker patients who develop atrial tachyarrhythmias : results of the ASSERT mechanisms of atrial fibrillation St (2011) (0)
763 The use of independently programmable configurations to optimize sensing and pacing and to decrease re-operation rates in CRT patients (2007) (0)
Current Use of Oral Anticoagulants Therapy in Pacemaker Patients With Pacemaker-Detected Atrial Fibrillation: Results From a Four-Nation Physician Survey (2013) (0)
Off-pump coronary bypass surgery. (2003) (0)
443 Role of electro-anatomical mapping of the right ventricle in evaluation of patients with unexplained cardiac arrest and familial sudden death (2011) (0)
4. Syncope Evaluation & Syncope Unit4.4 Application of the American College of Emergency Physicians (ACEP) Recommendations and a Risk Stratification System (OESIL) for Patients with Syncope Admitted in Internal Medicine Service (2005) (0)
Full Circle (2013) (0)
Efficacy of LAA Occlusion for Stroke Prevention (0)
Risk of mortality and stroke after atrial fibrillation – Authors' reply (2017) (0)
447 Role of adrenaline infusion in evaluation of patients with unexplained cardiac arrest and familial sudden death (2011) (0)
INFLUENCE OF ASSIGNING A DIAGNOSIS ON ARRHYTHMIA RECURRENCE IN APPARENTLY UNEXPLAINED CARDIAC ARREST PATIENTS (CASPER) (2015) (0)
598 Multidetector Cardiac CT Scan Coronary Sinus Anatomy in Patients Undergoing CRT Device Implantation (2012) (0)
Subgroup Data Reporting (2012) (0)
Systematic Review/Meta-analysis Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis (2013) (0)
Table 57, Results from Fixed-Effects Bayesian MTC Sub-Group Analysis for Major Bleeding Compared with Adjusted-Dose Warfarin by CHADS2 (2012) (0)
Abstract 20231: Effect of Coronary Ischemic Burden on Therapies for Ventricular Tachyarrhythmia (VT) and Death in Patients with an Implantable Cardioverter Defibrillator (ICD) (2010) (0)
642 Failed defibrillation testing among patients having ICD replacement: Incidence, predictors and influence of selection BIAS (2011) (0)
766 Prevention of Arrhythmia Device Infection Trial (PADIT): Pilot Study Results (2012) (0)
768 Prevalence and Predictors of Sub-Clinical Atrial Fibrillation in Pacemaker Patients (2012) (0)
Data Extraction Template (2012) (0)
Table 61, Summary of Unadjusted Fixed-Effects Bayesian MTC Results for Intracranial Bleeding Compared with Adjusted-Dose Warfarin (2012) (0)
Specificity of atrial high-rate episodes at different rates and durations: an analysis from the ASSERT trial (2011) (0)
PM198 Antithrombotic Treatment in Relation to Age and Stroke Risk in Patients With Newly Diagnosed Atrial Fibrillation (Gloria-AF Phase II) (2016) (0)
Figure 22, Rankogram for Unadjusted Fixed-effects Bayesian MTC Results for Myocardial Infarction* (2012) (0)
Table 65, Summary of Unadjusted Fixed-Effects Bayesian MTC Results for Major Gastrointestinal Bleeding Compared with Adjusted-Dose Warfarin (2012) (0)
ACTIVE W Substudy Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy: An Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in (2011) (0)
HIGH-VOLTAGE ICD LEAD IMPEDANCES ARE NOT INCREASED BY ROUTINE DEFIBRILLATION TESTING: Results FROM THE SIMPLE STUDY (2015) (0)
Reply: Effects of Cardiac Amyloidosis and Screening Approach on Left Atrial Thrombus Prevalence in Atrial Fibrillation. (2021) (0)
TWO-DIMENSIONAL ECHOCARDIOGRAPHY IN THE CORONARY CARE UNIT (1982) (0)
Erratum to: New pharmacotherapy for stroke prevention in atrial fibrillation (2010) (0)
Table 59, Summary of Unadjusted Fixed-Effects Bayesian MTC Results for All-cause Mortality Compared with Adjusted-Dose Warfarin (2012) (0)
PATIENT DECISIONAL NEEDS REGARDING SCREENING AND PROPHYLACTIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (2018) (0)
Surgical Checklist to Reduce Pacemaker and Implantable Cardioverter-Defibrillator Lead Dislodgements (2013) (0)
Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of long-QT syndrome probands (2013) (0)
A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era. (2016) (0)
HIGH PREVALENCE OF MODIFIABLE RISK FACTORS IDENTIFIED IN PHARMACY-BASED SCREENING PROGRAM (2016) (0)
MP09: Canadian Community Utilization of Stroke Prevention Pilot Study-Emergency Department (C-CUSP ED) (2017) (0)
The Case for and against Implantable Cardioverter Defibrillators in Patients with Coronary Artery Disease (2010) (0)
Abstract 14286: Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies (2016) (0)
Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy (2023) (0)
Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial (2021) (0)
Abstract 14622: Cardiac Resynchronization Therapy in Patients With RBBB in the Ontario ICD Registry; Assessment of Contemporary Practice and Outcomes. (2010) (0)
THE PHENOTYPIC SPECTRUM OF MOST FREQUENT MUTATION RESPONSIBLE FOR THE SHORT QT SYNDROME (2016) (0)
IMPACT OF BASELINE AND CHANGE IN MECHANICAL DYSSYNCHRONY ON LONG-TERM Outcomes IN THE RESYNCHRONIZATION-DEFIBRILLATION FOR AMBULATORY HEART FAILURE TRIAL (RAFT) (2015) (0)
Patient Inclusion and Exclusion Criteria from Included Studies (2012) (0)
Risk Estimates Reported and Computed (2012) (0)
Abstract 17226: Increased Risk of Heart Failure Associated With Left Atrial Remodeling Without Known Atrial Fibrillation (2018) (0)
638 Outcomes of primary prevention implantable cardioverter defibrillator (ICD) recipients with vs without clinical trial entry criteria: Observations from a comprehensive provincial ICD registry (2011) (0)
Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care (2023) (0)
Defibrillator discharges in a young patient: what is the underlying arrhythmia? (2014) (0)
EFFICACY OF ANTI-TACHYCARDIA PACING IN THE TREATMENT OF VENTRICULAR ARRHYTHMIAS IN THE RAFT TRIAL (2014) (0)
Table 45, Patient Inclusion and Exclusion Criteria (2012) (0)
Transcutaneous gas tension monitoring. (1983) (0)
Identification and in-silico characterization of splice-site variants from a large cardiogenetic national registry. (2022) (0)
OUTCOMES OF CARDIAC RESYNCHRONIZATION THERAPY IN ELDERLY PATIENTS WITH HEART FAILURE AND REDUCED LEFT VENTRICULAR EJECTION FRACTION: A META-ANALYSIS (2017) (0)
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
Abstract 18522: Exome Chip Analysis From the CASPER Registry Highlights Potential Genetic Variant Associated With Unexplained Cardiac Arrest (2014) (0)
B-PO01-020 MACHINE LEARNING TO PREDICT RECURRENT EVENTS FOLLOWING UNEXPLAINED CARDIAC ARREST (2021) (0)
RISK OF STROKE ASSOCIATED WITH ATRIAL FIBRILLATION AFTER NON-CARDIAC SURGERY: INSIGHTS FROM A META-ANALYSIS OF RANDOMIZED CONTROLLED STUDIES AND OBSERVATIONAL STUDIES (2016) (0)
Pulmonary Vein Diameter and Post Radiofrequency Ablation Atrial Fibrillation Recurrence: Does Size Matter? (2013) (0)
440 Role of Pre-Procedural Multidetector Cardiac CT Scan in Left Ventricular Lead Placement in Cardiac Resynchronization Therapy (CRT): A Pilot Study (2012) (0)
Abstract 17354: A Canadian Pilot Randomized Controlled Trial for a Decision Support Intervention in de novo Implantable Cardioverter Defibrillator Candidates - Main findings (2015) (0)
Table 1, Trial Characteristics of Included Studies (2012) (0)
Abstract 17221: Incidence of Pacemaker-Detected Atrial Tachyarrhythmias in Elderly Patients with Hypertension and a History of Stroke or Transient Ischemic Attack (2012) (0)
ICD R-WAVE DETERIORATION IN ARVC PATIENTS - DETERMINING THE OPTIMAL ICD LEAD PLACEMENT (2015) (0)
THE EFFECT OF EXERCISE ON ALL-CAUSE MORTALITY IN PATIENTS WITH SUBCLINICAL ATHEROSCLEROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2020) (0)
PHOSPHOLAMBAN CARDIOMYOPATHY: A CANADIAN PERSPECTIVE ON A UNIQUE DUTCH FOUNDER POPULATION (2016) (0)
Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment-Reply. (2019) (0)
P3252Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey Sean Healey?

Jeffrey Sean Healey is affiliated with the following schools:

Jeffrey Sean Healey's Academic­Influence.com Rankings

Why Is Jeffrey Sean Healey Influential?

Jeffrey Sean Healey's Published Works

Published Works

What Schools Are Affiliated With Jeffrey Sean Healey?

Jeffrey Sean Healey's AcademicInfluence.com Rankings